Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dalbavancin plasma concentrations in 133 patients: a PK/PD observational study.
Hervochon C, Hennart B, Leroy AG, Corvec S, Boutoille D, Senneville É, Sotto A, Illes G, Chavanet P, Dubée V, Bleibtreu A, De Carné MC, Talarmin JP, Revest M, Castan B, Bellouard R, Dailly É, Allorge D, Dinh A, Le Turnier P, Gregoire M; Dalbavancin Pharmacokinetics (DALBAP) study group. Hervochon C, et al. Among authors: senneville e. J Antimicrob Chemother. 2023 Dec 1;78(12):2919-2925. doi: 10.1093/jac/dkad331. J Antimicrob Chemother. 2023. PMID: 37864551
French national cohort of first use of dalbavancin: A high proportion of off-label use.
Dinh A, Duran C, Pavese P, Khatchatourian L, Monnin B, Bleibtreu A, Denis E, Etienne C, Rouanes N, Mahieu R, Bouchand F, Davido B, Lotte R, Cabaret P, Camou F, Chavanet P, Assi A, Limonta S, Lechiche C, Riou R, Courjon J, Illes G, Lacassin-Beller F, Senneville E; Dalbavancin French Study Group. Dinh A, et al. Among authors: senneville e. Int J Antimicrob Agents. 2019 Nov;54(5):668-672. doi: 10.1016/j.ijantimicag.2019.08.006. Epub 2019 Aug 7. Int J Antimicrob Agents. 2019. PMID: 31400471
Dalbavancin treatment for prosthetic joint infections in real-life: a national cohort study and literature review.
Matt M, Duran C, Courjon J, Lotte R, Moing VL, Monnin B, Pavese P, Chavanet P, Khatchatourian L, Tattevin P, Cattoir V, Lechiche C, Illes G, Lacassin-Beller F, Senneville E, Dinh A; Dalbavancin French Study Group. Matt M, et al. Among authors: senneville e. J Glob Antimicrob Resist. 2021 Jun;25:341-345. doi: 10.1016/j.jgar.2021.03.026. Epub 2021 May 4. J Glob Antimicrob Resist. 2021. PMID: 33962065 Free article. Review.
First report of the predominance of clonal complex 398 Staphylococcus aureus strains in osteomyelitis complicating diabetic foot ulcers: a national French study.
Senneville E, Brière M, Neut C, Messad N, Lina G, Richard JL, Sotto A, Lavigne JP; French Study Group on the Diabetic Foot. Senneville E, et al. Clin Microbiol Infect. 2014 Apr;20(4):O274-7. doi: 10.1111/1469-0691.12375. Epub 2013 Oct 2. Clin Microbiol Infect. 2014. PMID: 24118215 Free article.
Medical treatment of prosthetic vascular graft infections: Review of the literature and proposals of a Working Group.
Revest M, Camou F, Senneville E, Caillon J, Laurent F, Calvet B, Feugier P, Batt M, Chidiac C; Groupe de Réflexion sur les Infections de Prothèses vasculaires (GRIP). Revest M, et al. Among authors: senneville e. Int J Antimicrob Agents. 2015 Sep;46(3):254-65. doi: 10.1016/j.ijantimicag.2015.04.014. Epub 2015 Jun 6. Int J Antimicrob Agents. 2015. PMID: 26163735 Free article. Review.
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Poissy J, Belhadi D, Diallo A, Lê MP, Peytavin G, Staub T, Greil R, Guedj J, Paiva JA, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F; DisCoVeRy Study Group. Ader F, et al. Lancet Infect Dis. 2022 Feb;22(2):209-221. doi: 10.1016/S1473-3099(21)00485-0. Epub 2021 Sep 14. Lancet Infect Dis. 2022. PMID: 34534511 Free PMC article. Clinical Trial.
Efficacy of intravenous ofloxacin: a French multicentre trial in 185 patients.
Mouton Y, Leroy O, Beuscart C, Sivery B, Senneville E, Chidiac C, Beaucaire G, Vincent du Laurier M. Mouton Y, et al. Among authors: senneville e. J Antimicrob Chemother. 1990 Nov;26 Suppl D:115-21. doi: 10.1093/jac/26.suppl_d.115. J Antimicrob Chemother. 1990. PMID: 2286586 Clinical Trial.
Safety of Tedizolid as Suppressive Antimicrobial Therapy for Patients With Complex Implant-Associated Bone and Joint Infection due to Multidrug-Resistant Gram-Positive Pathogens: Results From the TediSAT Cohort Study.
Ferry T, Conrad A, Senneville E, Roux S, Dupieux-Chabert C, Dinh A, Lustig S, Goutelle S, Briot T, Pham TT, Valour F. Ferry T, et al. Among authors: senneville e. Open Forum Infect Dis. 2021 Jul 2;8(7):ofab351. doi: 10.1093/ofid/ofab351. eCollection 2021 Jul. Open Forum Infect Dis. 2021. PMID: 34337099 Free PMC article.
311 results